ArticleOncoTargets and therapy2025

Validation of a Combined Prognostic Score Using Plasma Tumor DNA and Clinical Features in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Taxanes.

Nicole Brighi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.